Tumor Change

Capomulin had a negative percent change whereas the others had a positive percent change. Thus, Capomulin preformed the best at decreasing the tumor volume. Ketapril preformed the worst at a 57% increase in tumor volume. This coincides with the conclusions in the other plots. Overall, Capomulin outpreformed the other three drugs in average tumor volume, metastatic spread, and survival rate.